Mark Edward Ruppen
61Patents
12h-index
94Co-inventors
87Inventor score
Filing activity: Jan 26, 1990 → Mar 29, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8153768B2 | Calicheamicin derivative-carrier conjugates | Chemistry; Metallurgy | 80 | Active |
| US8986710B2 | Neisseria meningitidis compositions and methods thereof | Human Necessities | 26 | Active |
| US8481692B2 | Compositions relating to a mutant Clostridium difficile toxin and methods thereof | Chemistry; Metallurgy | 22 | Active |
| US9561269B2 | Neisseria meningitidis compositions and methods thereof | Human Necessities | 18 | Active |
| US9724402B2 | Neisseria meningitidis composition and methods thereof | Human Necessities | 18 | Active |
| US9757443B2 | Non-lipidated variants of Neisseria meningitidis ORF2086 antigens | Emerging Cross-Sectional Technologies | 16 | Active |
| US9802987B2 | Immunogenic fusion polypeptides | Chemistry; Metallurgy | 16 | Active |
| US7396660B2 | Cloning genes from Streptomyces cyaneogriseus subsp. Noncyanogenus for biosynthesis of antibiotics and methods of use | Chemistry; Metallurgy | 16 | Expired |
| US7445916B2 | Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies | Chemistry; Metallurgy | 14 | Expired |
| US8652480B2 | Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides | Human Necessities | 14 | Active |
| US10226525B2 | Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | Emerging Cross-Sectional Technologies | 13 | Active |
| US7268144B2 | Regiospecific synthesis of rapamycin 42-ester derivatives | Chemistry; Metallurgy | 12 | Expired |
| US10512681B2 | Non-lipidated variants of Neisseria meningitidis ORF2086 antigens | Emerging Cross-Sectional Technologies | 11 | Active |
| US8900597B2 | Compositions relating to a mutant Clostridium difficile toxin and methods thereof | Chemistry; Metallurgy | 10 | Active |
| US10196429B2 | Neisseria meningitidis composition and methods thereof | Human Necessities | 10 | Active |
| US10550159B2 | Neisseria meningitidis composition and methods thereof | Human Necessities | 10 | Active |
| US8568735B2 | Immunogenic compositions of Staphylococcus aureus antigens | Chemistry; Metallurgy | 10 | Active |
| US9745354B2 | Compositions relating to a mutant Clostridium difficile toxin and methods thereof | Chemistry; Metallurgy | 9 | Active |
| US9950058B2 | RSV F protein mutants | Chemistry; Metallurgy | 8 | Active |
| US7538119B2 | 41-Methoxy isotope labeled rapamycin 42-ester | Chemistry; Metallurgy | 7 | Active |
| US8999697B2 | Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides | Human Necessities | 7 | Active |
| USRE46518E1 | Compositions relating to a mutant Clostridium difficile toxin and methods thereof | General | 7 | Active |
| US8747857B2 | Calicheamicin derivative-carrier conjugates | Chemistry; Metallurgy | 7 | Expired |
| US9187536B1 | Compositions relating to a mutant Clostridium difficile toxin and methods thereof | Chemistry; Metallurgy | 7 | Active |
| US9675681B2 | Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides | Human Necessities | 7 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.